WITH the weather finally getting better in the UK, it’s time to get back outside with the kids. According to the Met Office, ...

A pink glow beckons. Visitors remove their shoes and enter a spiral maze of salt and mirrors. In another room, some visitors ...

Book-A-Holic is a bibliophile’s dream come true. This isn’t just any bookstore; it’s a sprawling wonderland of words that ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...

Metsera and Maze Therapeutics are the second and third biotechnology firms this year to go public, raising $275 million and $140 million, respectively, in a pair of new stock offerings priced Thursday ...

The new Ooni Halo Pro Spiral Mixer is the brand's first stand mixer release, and it's designed to create "stronger gluten networks for better dough using its unique dual-kneading action." ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...